Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.46 Bil Enterprise Value: 31.84 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Q4 2021 Coloplast A/S Earnings Call Transcript

Nov 01, 2021 / 02:00PM GMT
Release Date Price: $160.73 (-3.88%)
Operator

Welcome to the Coloplast Full Year Financial Results 2020/'21 Conference Call. (Operator Instructions)

Today, I am pleased to present Kristian Villumsen, President and CEO; and Anders Lonning-Skovgaard, Executive Vice President and CFO. Please begin your meeting.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you, operator, and welcome, everybody. Good afternoon, and welcome to our full year 2021 conference call. I'm Kristian Villumsen, CEO of Coloplast, joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We're going to start with a short presentation by Anders and myself and then open up for questions like we usually do.

Please turn to Slide #3. I'm very satisfied with this year's results. We delivered 7% organic growth, a 33% EBIT margin before special items and a return on invested capital of 45% after tax and before special items. Broadly, across all markets, we continue to take market share.

In Q4, we delivered 10% organic growth and a 32%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot